These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33566198)

  • 1. Unravelling Toxoplasma treatment: conventional drugs toward nanomedicine.
    Jafarpour Azami S; Mohammad Rahimi H; Mirjalali H; Zali MR
    World J Microbiol Biotechnol; 2021 Feb; 37(3):48. PubMed ID: 33566198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
    el Kouni MH
    Curr Pharm Des; 2007; 13(6):581-97. PubMed ID: 17346176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metacytofilin Is a Potent Therapeutic Drug Candidate for Toxoplasmosis.
    Leesombun A; Iijima M; Umeda K; Kondoh D; Pagmadulam B; Abdou AM; Suzuki Y; Ohba SI; Isshiki K; Kimura T; Kubota Y; Sawa R; Nihei CI; Nishikawa Y
    J Infect Dis; 2020 Feb; 221(5):766-774. PubMed ID: 31573038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of lumefantrine as an effective drug against
    Wang D; Xing M; El-Ashram S; Ding Y; Zhang X; Sang X; Feng Y; Chen R; Wang X; Jiang N; Chen Q; Yang N
    Parasitology; 2021 Jan; 148(1):122-128. PubMed ID: 33087183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foodborne transmission of Toxoplasma gondii infection in the last decade. An overview.
    Almeria S; Dubey JP
    Res Vet Sci; 2021 Mar; 135():371-385. PubMed ID: 33148402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasion and egress by the obligate intracellular parasite Toxoplasma gondii: potential targets for the development of new antiparasitic drugs.
    Lavine MD; Arrizabalaga G
    Curr Pharm Des; 2007; 13(6):641-51. PubMed ID: 17346179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Toxoplasma activity of natural products: a review.
    Sepulveda-Arias JC; Veloza LA; Mantilla-Muriel LE
    Recent Pat Antiinfect Drug Discov; 2014; 9(3):186-94. PubMed ID: 25858302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii.
    Augusto L; Martynowicz J; Staschke KA; Wek RC; Sullivan WJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181373
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening.
    Deng Y; Wu T; Zhai SQ; Li CH
    Eur J Med Chem; 2019 Dec; 183():111711. PubMed ID: 31585276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antibacterials for the treatment of toxoplasmosis; a patent review.
    Rodriguez JB; Szajnman SH
    Expert Opin Ther Pat; 2012 Mar; 22(3):311-33. PubMed ID: 22404108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
    Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
    [No Abstract]   [Full Text] [Related]  

  • 12. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
    Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
    Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and Indirect Inhibition Effects of Resveratrol against
    Chen QW; Dong K; Qin HX; Yang YK; He JL; Li J; Zheng ZW; Chen DL; Chen JP
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30530601
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
    Murata Y; Sugi T; Weiss LM; Kato K
    PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential risk factors associated with seropositivity for Toxoplasma gondii among pregnant women and HIV infected individuals in Ethiopia: A systematic review and meta-analysis.
    Tarekegn ZS; Dejene H; Addisu A; Dagnachew S
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008944. PubMed ID: 33320848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextran sulfate inhibits acute Toxoplama gondii infection in pigs.
    Kato K; Murata Y; Horiuchi N; Inomata A; Terkawi MA; Ishiwa A; Ogawa Y; Fukumoto S; Matsuhisa F; Koyama K
    Parasit Vectors; 2016 Mar; 9():134. PubMed ID: 26956033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and Molecular Targets of Nucleotide-Tagged Trithiolato-Bridged Arene Ruthenium Complexes in the Protozoan Parasites
    Anghel N; Müller J; Serricchio M; Jelk J; Bütikofer P; Boubaker G; Imhof D; Ramseier J; Desiatkina O; Păunescu E; Braga-Lagache S; Heller M; Furrer J; Hemphill A
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639127
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for small molecule inhibitors of Toxoplasma gondii.
    Kortagere S
    Expert Opin Drug Discov; 2012 Dec; 7(12):1193-206. PubMed ID: 22998671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human toxoplasmosis-Searching for novel chemotherapeutics.
    Antczak M; Dzitko K; Długońska H
    Biomed Pharmacother; 2016 Aug; 82():677-84. PubMed ID: 27470411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
    McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
    ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.